Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Novel Ferroptosis-Related Gene Signature Predicts Overall Survival of Breast Cancer Patients
Haifeng Li, Lu Li, Cong Xue, et al.
Biology (2021) Vol. 10, Iss. 2, pp. 151-151
Open Access | Times Cited: 22

Showing 22 citing articles:

Comprehensive Analysis of Cuproptosis-Related Genes in Immune Infiltration and Prognosis in Melanoma
Haozhen Lv, Xiao Liu, Xuanhao Zeng, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 183
Regulatory pathways and drugs associated with ferroptosis in tumors
Dan Wang, Le Tang, Yijie Zhang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 6
Open Access | Times Cited: 84
SLC7A11/ xCT is a target of miR-5096 and its restoration partially rescues miR-5096-mediated ferroptosis and anti-tumor effects in human breast cancer cells
Poonam Yadav, Priyanshu Sharma, Sandhya Sundaram, et al.
Cancer Letters (2021) Vol. 522, pp. 211-224
Closed Access | Times Cited: 87
Identification of a Ferroptosis-Related LncRNA Signature as a Novel Prognosis Model for Lung Adenocarcinoma
Lu Lu, Leping Liu, Qiangqiang Zhao, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 77
Identification of a Ferroptosis-Related Signature Model Including mRNAs and lncRNAs for Predicting Prognosis and Immune Activity in Hepatocellular Carcinoma
Zi-An Chen, Hui Tian, Dongmei Yao, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 59
A New Ferroptosis-Related lncRNA Signature Predicts the Prognosis of Bladder Cancer Patients
Mei Chen, Zhenyu Nie, Yan Li, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 43
miR-545 promotes colorectal cancer by inhibiting transferring in the non-normal ferroptosis signaling
Sixin Zheng, Lingling Hu, Qingwen Song, et al.
Aging (2021) Vol. 13, Iss. 24, pp. 26137-26147
Open Access | Times Cited: 42
Upregulation of the ferroptosis-related STEAP3 gene is a specific predictor of poor triple-negative breast cancer patient outcomes
Lifang Yuan, Jiannan Liu, Lei Bao, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 14
A novel PD-1/PD-L1 pathway-related seven-gene signature for the development and validation of the prognosis prediction model for breast cancer
Peng Zhang, Jingjing Yang, Xiaolong Zhong, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 3, pp. 1554-1566
Open Access | Times Cited: 5
Targeting the initiator to activate both ferroptosis and cuproptosis for breast cancer treatment: progress and possibility for clinical application
Murshid Imam, Jiale Ji, Zhijie Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Ferroptosis regulators, especially SQLE, play an important role in prognosis, progression and immune environment of breast cancer
Wenqing Tang, Fangshi Xu, Meng Zhao, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 29
Construction and Validation of a Ferroptosis-Related Prognostic Signature for Melanoma Based on Single-Cell RNA Sequencing
Yating Liu, Yanhong Shou, Ronghui Zhu, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 18
Phytochemicals Targeting Ferroptosis: Therapeutic Opportunities and Prospects for Treating Breast Cancer
Xinyi Zhao, Xueni Wang, Yuzhou Pang
Pharmaceuticals (2022) Vol. 15, Iss. 11, pp. 1360-1360
Open Access | Times Cited: 15
MiR-148a-3p Promotes Colorectal Cancer Cell Ferroptosis by Targeting SLC7A11
Elisa Martino, Anna Balestrieri, Francesca Aragona, et al.
Cancers (2023) Vol. 15, Iss. 17, pp. 4342-4342
Open Access | Times Cited: 7
Ferroptosis-Related lncRNA Signature Correlates with the Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity of Esophageal Squamous Cell Carcinoma
Jiahao Zhu, Yutian Zhao, Gang Wu, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-29
Open Access | Times Cited: 11
Cuproptosis-related lncRNAs predict the prognosis and immune response in hepatocellular carcinoma
Qiongyue Zhang, Yan Huang, Yu Xia, et al.
Clinical and Experimental Medicine (2022) Vol. 23, Iss. 6, pp. 2051-2064
Closed Access | Times Cited: 11
Bioinformatic analysis indicated that STARD4-AS1 might be a novel ferroptosis-related biomarker of oral squamous cell carcinoma.
Jiahui Li, Zihe Qiao, Yuwei Li, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e33193-e33193
Open Access | Times Cited: 1
Correlation between Ferroptosis-Related Gene Signature and Immune Landscape, Prognosis in Breast Cancer
Jiahao Zhu, Qingqing Chen, Ke Gu, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-19
Open Access | Times Cited: 6
Pre-Clinical Insights into the Iron and Breast Cancer Hypothesis
Henry J. Thompson, Elizabeth S. Neil, John N. McGinley
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1652-1652
Open Access | Times Cited: 8
Identifying DLAT as a novel therapy target based on integration analysis of the cuproptosis regulatory genes for hepatocellular carcinoma
Xiao–Wen Guan, Zhentao Liu, J H Wang, et al.
(2024) Vol. 4, Iss. 3
Open Access
Ferroptosis-Related lncRNA Signature Predicts Prognosis and Immunotherapy Efficacy in Cutaneous Melanoma
Yujian Xu, Youbai Chen, Zehao Niu, et al.
Research Square (Research Square) (2022)
Closed Access | Times Cited: 2
ACSF2: A MEDIUM-CHAIN ACYL-CoA SYNTHETASE WITH A POTENTIAL ROLE IN NEURONAL DIFFERENTIATION
Dony Maiguel, Masashi Morita, Zhengtong Pei, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top